Olema Pharmaceuticals, Inc. Common Stock (OLMA)
PHARMACEUTICAL PREPARATIONS
Olema Pharmaceuticals, Inc. Common Stock (OLMA) is listed on Nasdaq, where it has traded since November 19, 2020.
- Listed On
- Nasdaq
- Listed Since
- November 19, 2020
- Employees
- 150
- Market Cap
- $655M
About Olema Pharmaceuticals, Inc. Common Stock
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 175 institutions reported holding OLMA, with 101.3 million shares worth $1.3 billion in aggregate. The largest reported holder was FMR, with 12.1 million shares worth $151.9 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 12,143,062 | $152M | Added 16.91% |
| Paradigm Biocapital Advisors | 8,670,576 | $108M | Added 8.1% |
| Janus Henderson (Jupiter Topco) | 7,094,413 | $89M | Reduced 0.2% |
| Bain Capital Life Sciences Investors | 7,085,249 | $89M | Reduced 5.19% |
| BlackRock | 6,714,691 | $84M | Added 18.8% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is OLMA?
Olema Pharmaceuticals, Inc. Common Stock (OLMA) is listed on Nasdaq, where it has traded since November 19, 2020.
Who are the largest institutional holders of OLMA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of OLMA were FMR, Paradigm Biocapital Advisors and Janus Henderson (Jupiter Topco).
How many institutions own OLMA?
175 institutions reported a position in OLMA for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell OLMA last quarter?
Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for OLMA.
Every reported institutional holder, plus insider and congressional trades in OLMA, on SentiSense.